Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New ATR kinase inhibitors discovered at Shenzhen Life Fountain Biotech

Dec. 21, 2021

Hongyun Biotech identifies new EGFR inhibitors

Dec. 21, 2021

Axial Therapeutics discovers Toll-like receptor 2 agonists

Dec. 20, 2021

New three-prime repair exonuclease 1 inhibitors synthesized at Constellation Pharmaceuticals

Dec. 20, 2021

Senda Biosciences identifies aryl hydrocarbon receptor antagonists

Dec. 20, 2021

New CDK7 inhibitors discovered at Lilly

Dec. 20, 2021

Janssen describes new dihydroorotate dehydrogenase inhibitors

Dec. 20, 2021

Janssen discloses DHODH inhibitors

Dec. 17, 2021

Eli Lilly and Company presents new NTRK1 inhibitors

Dec. 17, 2021

Pfizer synthesizes new JAK1 inhibitors

Dec. 17, 2021

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...